Clinical trial
Efficacy and Safety of Diamyd® in Children and Adolescents With Type 1 Diabetes
NCT00435981 · Diamyd Therapeutics AB, Industry · Completed
Key facts
| NCT number | NCT00435981 |
|---|---|
| Title | Efficacy and Safety of Diamyd® in Children and Adolescents With Type 1 Diabetes |
| Official title | A Phase II, Randomised, Double-Blind, Placebo-Controlled, Multi-Centre Study to Investigate the Impact of Diamyd® on the Progression of Diabetes in Patients Newly Diagnosed With Type 1 Diabetes Mellitus |
| Lead sponsor | Diamyd Therapeutics AB, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Type 1 Diabetes |
| Intervention type | Drug |
| Interventions | rhGAD65 formulated in Alhydrogel® (Diamyd®) |
| Enrollment | 70 |
| Start date | Jan 1, 2005 |
| Primary completion | Oct 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Feb 16, 2007 |
| Last update posted | Jan 30, 2008 |
| Countries | Sweden |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: